RPL7P61

Across TCGA pan-cancer cohorts, RPL7P61 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL7P61’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RPL7P61 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL7P61 is over-expressed in tumor.

HNSC, KIRC, and LUAD are the cancer types where RPL7P61 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7P61 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+0.068	.003	6	view →
KIRC	All	All	+0.016	.006	4	view →
LUAD	All	II,III,IV	+0.029	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL7P61–HNSC

Open the HNSC breakdown →